Envista Holdings Corp（NVST）の株式分析NVSTEnvista Holdings Corp

Envista Holdings Corporation provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a provider of a range of solutions to support dental implants, orthodontic treatments, dental diagnostics, general dental consumable products, equipment and services. Its segments include Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, lab products, and loupes. The Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

Envista Holdings Corp is a good buy right now due to its current price of $23.60, which is below the analyst consensus target of $31.32, indicating a potential upside of 32.5%. Additionally, the company's forward P/E ratio of 16.81 suggests it is reasonably valued compared to its growth prospects. The recent upgrade by JP Morgan reflects confidence in the company's financial health and operational efficiency, especially after beating EPS estimates by 24.24% in the last earnings report. However, the main risk is the downward pressure on revenue due to a temporary inventory drawdown, which could impact Q3 results, as highlighted by BMO Capital.